Executive Profile

Standish M. Fleming Managing Member, Forward Ventures

Age	Total Calculated Compensation	This person is connected to 2 Board Members in 2 different organizations across 9 different industries. See Board Relationships
65	--

Background

Mr. Standish M. Fleming, Stan, is a Managing Member at Forward Ventures. He co-founded the firm in 1993 and also served in an advisory position with Forward Ventures from February 1992 through April 1993. Mr. Fleming has helped start more than 15 companies, and served at founding Chief Executive Officer of eight. At Forward, he has invested in almost every segment of the health-care industry, including pharmaceuticals, biologics, diagnostics, devices, services, and software. ... Mr. Fleming has managed both platform and product companies and investments in the portfolio and led or participated in financings at all levels from pre-start-up to PIPES in public companies, in both debt and equity. He has helped raise and manage six venture funds totaling more than $500 million and has served on the Boards of 19 venture-backed companies. Mr. Fleming is a 22 year veteran of early-stage venture capital and biotech investing. Before establishing Forward Ventures II in 1993, he served as the President, and Chief Executive Officer of GeneSys Therapeutics. Mr. Fleming served as the initial President and Chief Executive Officer of Triangle Pharmaceuticals, Actigen, GenQuest, Deltagen, and CombiChem. He was the President of the Biotechnology Venture Investors Group. He currently serves as a Director of Ambit Biosciences, Ambit, Sanarus Medical Inc, and Nereus Pharmaceuticals, Inc. He was a Director of Gryphon Therapeutics, Arizeke Pharmaceuticals, Tandem Medical, and Kémia. He has been a Director of CONNECT, Triangle Pharmaceuticals, Inc. since July 1995. Mr. Fleming was a founding Board Member of Ciphergen Biosystems, Triangle Pharmaceuticals, and Gryphon Sciences. He formerly served on the boards of Acorda Therapeutics, Converge Medical, Doctors on Line, EndiCOR, First Dental Health, IntensiCare, and MitoKor. Mr. Fleming was also the Chairman at GeneSys Therapeutics. He earned an M.B.A. from the UCLA Graduate School of Management and a B.A. from Amherst College.

Corporate Headquarters 9393 Towne Centre Drive San Diego, California 92121 United States Phone: 858-677-6077 Fax: 858-452-8799 Board Members Memberships Prior Vermillion, Inc. Director Gryphon Therapeutics, Inc. Director MIGENIX Corp. Director Nereus Pharmaceuticals, Inc. Director Tandem Medical, Inc. Former Director Sanarus Technologies, LLC Former Director Converge Medical, Inc. Director Kémia, Inc. Director Arizeke Pharmaceuticals Inc. 1995-N/A Former Director Triangle Pharmaceuticals, Inc. 2001-Present Director and Chairman of Audit Committee Ambit Biosciences Corporation 2004-2006 Former Director and Member of Audit Committee Acorda Therapeutics, Inc. Education BA Amherst College MBA University of California-Los Angeles MBA UCLA Anderson School of Management Other Affiliations Ventana Capital Management, LLC Acorda Therapeutics, Inc. Vermillion, Inc. Corixa Corporation Gryphon Therapeutics, Inc. MIGENIX Corp. Nereus Pharmaceuticals, Inc. Tandem Medical, Inc. Triangle Pharmaceuticals, Inc. Sanarus Technologies, LLC Converge Medical, Inc. Ambit Biosciences Corporation Kémia, Inc. Arizeke Pharmaceuticals Inc. Forward Ventures II, L.P. Forward Ventures IV, L.P. University of California-Los Angeles Amherst College Forward Ventures V, L.P. Biotechnology Venture Investors Group GeneSys Therapeutic Corp. UCLA Anderson School of Management

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.